Arrhythmogenic right ventricular dysplasia

From WikEM
Jump to: navigation, search

Background

  • ARVD is a significant contributor to sudden cardiac death in young patients
    • Second most common cause of sudden cardiac death in young adults and athletes after hypertrophic obstructive cardiomyopathy (HOCM)
  • More common in males and those of Mediterranean descent
    • M:F = 3:1
  • 1:1000-10,000 in the US
  • Fibro-fatty replacement of myocardium

Clinical Features

  • Palpitations (27%)
  • Syncope (26%)
  • Ventricular dysrhythmia/cardiac arrest (23%)
  • Family history of unexplained syncope or sudden death
  • Dysrhythmias refractory to anti-dysrhythmic meds
  • Asymptomatic (40%)
    • Usually these patients are identified through genetic testing of an affected or symptomatic family member
  • Right ventricular failure (6%)
  • Dyspnea
  • Atypical chest pain (6%)

Differential Diagnosis

Cardiomyopathy

Syncope Causes

T Wave Inversions

Evaluation

ECG

ARVD.png

  • Epsilon wave (30-50%)
  • V1-V3 TWI (especially in patients >14 yrs old) (85%)
  • V1-V3 QRS widening
  • Sudden VT episodes with a LBBB morphology
  • Prolonged S-wave upstroke of 55 ms in V1-3 (95%)

Imaging

Major and minor criteria rely on echo and cardiac MRI

  • Echo - hypokinetic and dilated RV, dilation of RVOT
  • Cardiac MRI - fibro-fatty change with RV myocardial thinning, RV aneurysms, RV dilatation

Management

  • Sotalol is the preferred anti-dysrhythmic
  • Manage heart failure in the usual manner

Disposition

  • Symptomatic presentation: Admission to cardiology
  • Incidental finding: Cardiology follow-up for further risk assessment and possible ICD placement or ablation

References

  • Anderson EL. Arrhythmogenic right ventricular dysplasia. Am Fam Physician. 2006 Apr 15;73(8):1391-8.
  • Perez Diez D, Brugada J. Diagnosis and Management of Arrhythmogenic Right Ventricular Dysplasia. E-Journal of the ESC Council for Cardiology Practice, European Society of Cardiology 2008.